Aronia Cold-Press vs. Spray-Dry: Processing & EU Compliance

Why Processing Route Is a Regulatory Decision, Not Just a Technical One

Aronia melanocarpa — the black chokeberry — has earned its place as one of Europe's most anthocyanin-dense botanical raw materials. With ORAC values routinely exceeding 16,000 µmol TE/100g and polyphenol profiles dominated by cyanidin-3-galactoside, procyanidin B2, and chlorogenic acid, demand from cosmetic formulators, nutraceutical brands, and functional food developers continues to climb.

But here is the decision that catches many sourcing teams off guard: the processing route you specify at the point of purchase directly determines your regulatory classification, labelling obligations, and time-to-market in the EU. Cold-pressed juice concentrates and spray-dried powders are not interchangeable from a compliance standpoint — and conflating them can cost months of reformulation or, worse, a market withdrawal.

---

Cold-Press Aronia: Bioactives Intact, Regulatory Path Well-Trodden

What It Is

Cold-press processing mechanically extracts juice from aronia berries at temperatures typically below 45°C, preserving the thermolabile anthocyanin fraction. The resulting juice or concentrate is then standardised by Brix value — commonly 65–70° Brix for concentrates — with no carrier agents, maltodextrins, or processing aids introduced.

EU Food Regulatory Status

Aronia juice concentrate has a documented history of consumption in Central and Eastern Europe predating the EU Novel Food Regulation (EU) 2015/2283. Suppliers operating with traceability records from Poland, Bulgaria, or Germany — where aronia cultivation is well-established — can substantiate a pre-Union history of safe use, placing cold-pressed concentrates outside the Novel Food trigger provided the product is not significantly modified.

Key compliance checkpoints for cold-press:

• Confirm supplier can provide country-of-origin cultivation records dating consumption history
• Verify the product has not undergone processes that substantially alter bioavailability (e.g., enzyme-assisted extraction counted separately)
• For functional food applications, Article 13.1 health claims referencing polyphenols or antioxidant activity require substantiation under EFSA; standalone antioxidant claims for the end consumer remain unauthorised on EU labels

Cosmetic INCI Registration

For topical applications, cold-pressed aronia juice enters formulations under the INCI designation Aronia Melanocarpa Fruit Extract or Aronia Melanocarpa Juice. Both designations are listed in the CosIng database managed by the European Commission. No pre-market notification or safety assessment specific to the ingredient is mandated by the Cosmetics Regulation (EC) No 1223/2009 — though the finished product safety assessment under Annex I must account for anthocyanin-derived colourant activity and potential skin sensitisation data.

---

Spray-Dried Aronia Powder: Higher Versatility, Greater Regulatory Scrutiny

What It Is

Spray drying transforms aronia juice or extract into a free-flowing powder by atomising the liquid feed into a hot-air chamber (inlet temperatures typically 160–200°C). Carrier agents — most commonly maltodextrin (DE 10–20) or acacia gum — are introduced at ratios of 1:1 to 4:1 (carrier:solids) to protect heat-sensitive polyphenols and ensure powder stability. Some manufacturers apply encapsulation technologies — cyclodextrin inclusion or liposomal matrices — to further enhance bioavailability.

EU Food Regulatory Status

This is where the regulatory risk diverges sharply from cold-press. The spray-drying process itself does not trigger Novel Food status — provided the source material retains its pre-Union history of use. However, several scenarios escalate scrutiny:

• Modified bioavailability: If encapsulation (e.g., cyclodextrin complexation) demonstrably alters polyphenol absorption kinetics, the product may qualify as a Novel Food under Article 3(2)(a)(iv) of Regulation (EU) 2015/2283, requiring authorisation before EU market placement
• Carrier agent classification: Maltodextrin carriers are broadly accepted as food additives (E1400 series) or food ingredients; however, novel carrier systems require independent assessment
• Concentration standardisation: Powders standardised to unusually high anthocyanin levels (>25% anthocyanins by dry weight) may attract EFSA scrutiny over maximum safe intake levels, particularly in nutraceutical capsule formats

R&D teams should submit a pre-submission enquiry to the European Commission's Novel Food catalogue if any processing modification introduces uncertainty. The catalogue currently lists *Aronia melanocarpa* products with a status note acknowledging traditional use — but does not provide blanket clearance for all derived formats.

Cosmetic INCI Registration

Spray-dried aronia powder faces additional steps in the cosmetic channel. If the supplier's manufacturing process introduces carrier materials or encapsulants not individually listed in CosIng, the formulator must ensure each component has its own INCI entry. The finished blend may require listing as a multi-component ingredient, increasing CPSR (Cosmetic Product Safety Report) complexity.

For encapsulated aronia systems, the responsible person under the Cosmetics Regulation must also evaluate whether the encapsulation technology constitutes a nanomaterial under Article 2(1)(k), triggering a mandatory nano-notification to the European Commission at least six months before market launch.

---

Side-by-Side Compliance Summary

| Parameter | Cold-Press Concentrate | Spray-Dried Powder |

|---|---|---|

| Novel Food trigger risk | Low (established history) | Medium–High (process-dependent) |

| INCI CosIng listing | Direct, single entry | May require multi-component listing |

| Nano-notification risk | Negligible | Present if encapsulated |

| Shelf life (typical) | 12–18 months (refrigerated) | 24–36 months (ambient) |

| Anthocyanin retention | 85–95% post-processing | 60–80% post-processing |

| Dosage form suitability | Liquids, beverages, topicals | Capsules, tablets, dry blends, creams |

---

Procurement Recommendations for Sourcing Teams

• Request full process documentation from suppliers, including inlet/outlet temperatures, carrier agent specifications, and any encapsulation technology used — this is non-negotiable for Novel Food dossier preparation
• Prioritise suppliers with EU-based cultivation and processing who can provide chain-of-custody records supporting pre-Union consumption history
• Align your regulatory affairs team early: the decision between cold-press and spray-dry should be made before formulation lock, not after
• For cosmetic applications, always verify the supplier's CosIng compatibility and request a Certificate of Analysis referencing INCI-aligned nomenclature
• Consider dual sourcing: some leading B2B suppliers offer both formats from the same certified botanical origin, enabling parallel regulatory pathways during product development

---

The Bottom Line

Aronia's regulatory profile is more nuanced than its commercial popularity suggests. Cold-press concentrates offer a cleaner compliance pathway for both food and cosmetic applications, while spray-dried formats unlock superior formulation flexibility at the cost of additional regulatory due diligence. The optimal sourcing decision depends on your final application, dosage form, and the specific modifications applied during processing — and that decision should be made with documented supplier data in hand, not assumptions.

On TANDOR, aronia listings are required to specify processing method, carrier agent composition, and available certification documentation, giving your procurement and regulatory teams the transparency needed to make this call with confidence.